The histone acetyltransferases (HATs) of the MYST family are highly conserved in eukaryotes and carry out a significant proportion of all nuclear acetylation. These enzymes function exclusively in multisubunit protein complexes whose composition is also evolutionarily conserved. MYST HATs are involved in a number of key nuclear processes and play critical roles in genespecific transcription regulation, DNA damage response and repair, as well as DNA replication. This suggests that anomalous activity of these HATs or their associated complexes can easily lead to severe cellular malfunction, resulting in cell death or uncontrolled growth and malignancy. Indeed, the MYST family HATs have been implicated in several forms of human cancer. This review summarizes the current understanding of these enzymes and their normal function, as well as their established and putative links to oncogenesis.
Introduction
The eukaryotic genome is assembled into chromatin -a complex structure of DNA and proteins. The basic unit of chromatin is the nucleosome, comprised of 146 bp of DNA wound around a histone octamer made up of two copies of each core histone -H2A, H2B, H3 and H4. The nucleosomes, in turn, are arranged into several tiers of higher-order structures that allow for packaging of the genome into the small confines of the nucleus (Horn and Peterson, 2002) . In addition to its compactness, chromatin must also be very flexible and dynamic to permit various DNA-based nuclear processes such as DNA transcription, replication and damage repair. To this end, the local chromatin structure is continuously modified to make it more or less accessible to nonchromatin proteins. The two major classes of enzymes involved in such rearrangements are chromatin remodellers and histone modifiers (Vaquero et al., 2003) . The former use the energy produced by ATP hydrolysis to reposition or remove nucleosomes, or to alter their composition by introducing histone variants. The histone-modifying enzymes, on the other hand, add or remove a variety of chemical moieties to histone residues. Covalent histone modifications include acetylation, methylation, phosphorylation, ubiquitination and others. According to the 'histone code' hypothesis (Jenuwein and Allis, 2001) , such modifications on a single or on several neighbouring nucleosomes combine to produce a specific effect on the local chromatin structure, and to form a signal that can be interpreted and acted upon by non-chromatin proteins. Acetylation -the earliest described histone modification (Phillips, 1963 ) -involves the transfer of an acetyl group from acetyl-CoA to the e-amino group of a lysine residue by a diverse class of enzymes collectively known as histone acetyltransferases (HATs). HATs have been identified in a variety of eukaryotic organisms from yeast to human, and are classified into several families based on their structural homologies. This review describes the diverse functions of several HATs from the prominent MYST family, and highlights their established and putative links to cancer.
MYST family of histone acetyltransferases
The HATs belonging to the MYST family play key roles in post-translational modification of histones and thus have a profound effect on chromatin structure in the eukaryotic nucleus. Originally named for its four founding members in yeast and mammals, the family currently comprises five human HATs: Tip60, MOZ, MORF, HBO1 and MOF. Their defining feature is the presence of the highly conserved MYST domain composed of an acetyl-CoA binding motif and a zinc finger. Some family members also have in common additional structural features such as chromodomains, plant homeodomain-linked (PHD) zinc fingers, and others ( Figure 1a ) (Utley and Cote, 2003; Yang, 2004) . Orthologues of the MYST HATs are known to exist in many lower eukaryotes, and the multisubunit protein complexes in which they function are also evolutionarily conserved. MYST family HATs are involved in a wide variety of critical nuclear processes, and as such it is not surprising that their (mal-)functions have been associated with a number of human diseases including cancer. This review will focus on the Tip60, HBO1 and MOZ/MORF acetyltransferases, their associated protein complexes and their links to human oncogenesis; for reviews on MOF and yeast MYST HATs, see two separate articles in this issue (Lafon et al., 2007; Rea et al., 2007) . This review will also briefly discuss the inhibitor of growth (ING) family of tumour suppressors whose functions are tightly linked to those of the MYST HATs.
Tip60
Tip60 in transcriptional activation Tip60 (HIV Tat-interacting protein of 60 kDa, (Kamine et al., 1996) ) is the catalytic subunit of the evolutionarily conserved NuA4 (nucleosome acetyltransferase of histone H4) complex (Figure 1b) (Doyon et al., 2004) . This HAT has a well-characterized involvement in transcriptional regulation, functioning as a co-activator for such key cellular proteins as nuclear hormone receptors (Brady et al., 1999; Gaughan et al., 2001 Gaughan et al., , 2002 , b-catenin (Sierra et al., 2006) , nuclear factor-kB (NF-kB) (Baek et al., 2002) , c-Myc oncoprotein (Frank et al., 2003) and E2F (Taubert et al., 2004) .
An important functional link is also emerging between Tip60 and transcription mediated by the p53 tumour suppressor. A large-scale RNA interferencebased screen revealed that Tip60 is required for induction of apoptosis by p53 (Berns et al., 2004) , whereas separate studies demonstrated that the HAT acts as p53's transcriptional co-activator (Doyon et al., 2004; Legube et al., 2004) . These observations have since been confirmed and extended with the discovery that at least one other NuA4 subunit -p400 -is also involved in this function (Tyteca et al., 2006) . Recently, two groups have begun to elucidate the molecular mechanisms behind the Tip60-p53 functional interaction after observing that Tip60 (as well as MOF) specifically acetylates lysine 120 (K120) of p53 upon DNA damage. This modification within p53's DNA-binding domain appears to influence the tumour suppressor's choice of gene promoters, thereby modulating the switch of cell fate from cell-cycle arrest to apoptosis (Sykes et al., 2006; Tang et al., 2006) . The new observations are in line with an earlier finding that an inactivating mutation within Tip60's HAT domain results in an inefficient induction of apoptosis upon DNA damage (Ikura et al., 2000) . Notably, the discovery of p53K120 acetylation by Tip60 is one of the first instances where a posttranslational modification of p53 has been mapped to a residue sometimes mutated in cancer.
Tip60 and DNA damage repair
The involvement of Tip60 in the cell's response to DNA damage is not limited to p53 acetylation. In addition to reduced capacity for apoptosis, cells harbouring the HAT-null Tip60 mutant were also found to be inefficient in mending DNA double-strand breaks (DSBs), suggesting that Tip60 plays a role in the actual (Doyon et al., 2004 (Doyon et al., , 2006 Smith et al., 2005) .
MYST acetyltransferases and cancer N Avvakumov and J Côté process of DNA repair (Ikura et al., 2000) . Indeed, the HAT has been shown to acetylate and thereby activate another key player in the DNA repair pathway -the ATM (ataxia telangiectasia mutated) kinase . Activated ATM rapidly and robustly phosphorylates a number of direct targets, p53 among them, and also initiates a series of phosphorylation cascades by acting upon other kinases (reviewed in Shiloh, 2003; Sancar et al., 2004) . Thus, several outcomes are triggered by Tip60-mediated ATM activation. Phosphorylation of targets such as p53, in concert with its acetylation by Tip60, leads to cell-cycle arrest or apoptosis, presumably depending on the amount and severity of damage sustained by the genome. Another notable direct target of ATM, the histone variant H2AX is also rapidly phosphorylated (Shroff et al., 2004) . Foci of phospho-H2AX (gH2AX) surround megabases of DNA around the DSB (Rogakou et al., 1999; Bewersdorf et al., 2006) , demarcating the site of damage and aiding in recruitment and/or retention of repair proteins. Thus, Tip60 is intimately involved in initiation of the signalling cascades and other early cellular responses to DNA damage. Additionally, Tip60 also plays a role in the repair itself. In yeast Saccharomyces cerevisiae, the NuA4 complex has been detected at the sites of DSB. Its recruitment and/or retention at the break site is mediated by the Arp4 subunit which recognizes phosphorylated histone H2A (gH2A, the yeast equivalent of gH2AX) (Downs et al., 2004) . Thus, this suggests that the mark deposited at the DSB by Tip60-activated ATM results in localization of Tip60 to the site. Chromatin immunoprecipitation (ChIP) assays have also detected Tip60 and TRRAP -another NuA4 subunit -at the site of DSB in mammalian cells. Introduction of a dominant-negative mutant of Tip60 resulted in impairment of DSB repair due to inefficient recruitment of repair machinery to the site of the break. Presumably, this is caused by the failure of the surrounding chromatin to relax -an event that is normally facilitated by hyperacetylation of histone H4 by the human NuA4 complex (Murr et al., 2006) . Finally, Tip60 is also involved in 're-setting' of the DNA damage signalling system once repair is complete. A study carried out in Drosophila has demonstrated that Tip60 together with p400 catalyse the exchange of phosphorylated H2Av (gH2AX equivalent) with unmodified H2Av (Kusch et al., 2004) , removing the DNA damage mark. The free gH2Av can then be dephosphorylated as signal for checkpoint release (Chowdhury et al., 2005; Keogh et al., 2006) . Overall, it has become clear that Tip60 and the entire NuA4 complex are critically involved in all the major steps of the DNA repair process.
Tip60 and cancer
Given the roles of Tip60 in transcriptional activation and DNA repair, it is not surprising that this HAT has been linked to a number of human diseases. Its original identification as an HIV Tat-interacting protein immediately connected it to HIV infection and AIDS, and several subsequent observations support this notion (Creaven et al., 1999; Col et al., 2005) . Additionally, compelling evidence links Tip60 to the onset of Alzheimer's disease Sudhof, 2001, 2004; Baek et al., 2002; Kinoshita et al., 2002) . A significant body of work also suggests its involvement in oncogenesis or in resistance to cancer (Figure 2 ), although in many cases the direct mechanistic evidence is still lacking. In all cases described so far, Tip60 does not act directly as a tumour suppressor or an oncogene, but rather facilitates the actions of other such proteins by virtue of being a general acetyltransferase and transcriptional co-activator. For instance, further investigation of the link between Tip60 and p53 discussed above is likely to elucidate a pathway to tumour progression that involves prevention of acetylation of p53 by Tip60. Indeed, a recent large-scale screen revealed a significant downregulation of Tip60 expression in tissues from colon and lung carcinomas (LLeonart et al., 2006) . Given the mechanistic evidence by Sykes et al. (2006) and Tang et al. (2006) , it is possible to speculate that this results in hypoacetylation of p53K120 upon genotoxic stress, which in turn steers the cell away from apoptosis and towards cell-cycle arrest. By increasing the cell's chances of survival in the face of DNA damage that would normally result in the initiation of the cell death programme, this can lead to malignancy. On the other hand, upregulation of Tip60 has also been recently linked to promotion of epithelial tumorigenesis (Hobbs et al., 2006) .
Other evidence linking Tip60 to cancer includes the observation that acetylation by this HAT activates the androgen receptor (AR) -a hormone-dependent transcription factor whose malfunction is strongly implicated in the onset of prostate cancer (Brady et al., 1999; Gaughan et al., 2001 Gaughan et al., , 2002 . Another study has linked Tip60 to progression of prostate cancer cells to hormone independence and resistance to chemotherapy. Nuclear Tip60 was found to accumulate with increasing hormone independence, and its high levels allowed it to act as a co-activator of the AR in the absence of ligand (Halkidou et al., 2003) . Thus, upregulation of Tip60 may permit advanced prostate cancer cells to survive in a hormone-independent fashion.
The recruitment of Tip60 and other NuA4 components by the c-Myc transcription factor has also been reported (Frank et al., 2003) . This protooncogene is a potent promoter of cellular growth and proliferation, and is often deregulated in a variety of human cancers (Nesbit et al., 1999) . The interaction between Tip60 and c-Myc is further stabilized by the p30II protein expressed by the human T-cell lymphotropic virus type-1 (HTLV-1). This results in a further enhancement of c-Myc's transforming potential in a manner dependent on Tip60's HAT activity (Awasthi et al., 2005) . Thus, Tip60 may play a role in the induction of adult T-cell leukaemia/lymphoma by HTLV-1 and other cancers involving the c-Myc oncogene.
The observed involvement of Tip60 in the expression of NF-kB-regulated genes, including the KAI1 metastasis suppressor gene (Baek et al., 2002; Kim et al., 2005) , suggests that the HAT may play a general role in the wide variety of NF-kB activities. This family of transcription factors is involved in regulation of a large number of genes that participate in diverse cellular functions (Radhakrishnan and Kamalakaran, 2006) . Notably, such target genes include signalling molecules like cytokines and chemokines, and effectors of apoptosis and cell proliferation. NF-kB is considered an oncogene due to its ability to activate growth promoting and antiapoptotic genes, and can also promote metastasis. An interaction between Tip60 and the interleukin-9 (IL-9) receptor has also been reported (Sliva et al., 1999) . Although the functional consequences of this association are unknown, it may prove to have a significant impact on human health as IL-9 signalling has been linked to Hodgkin's lymphoma and asthma (Renauld, 2001; Knoops and Renauld, 2004) .
On a more positive note, Tip60 has also been linked to the p14ARF tumour suppressor. This protein has a wellestablished role in controlling p53-mediated cell-cycle arrest, but is also known to function independently of p53. In support of this, one recent investigation has demonstrated that, in response to genotoxic stress, a direct physical interaction between p14ARF and Tip60 results in activation of the ATM/CHK signalling cascade and arrest of the cell cycle in the G2 phase . Intriguingly, in another study, the same group observed that acetylation of the retinoblastoma (Rb) tumour suppressor by Tip60 targeted it for proteasomal degradation, an activity blocked by p14ARF upon genotoxic stress . Although this finding needs to be independently verified, it suggests a novel role for Tip60 in regulation of Rb homeostasis. Presumably, the acetyltransferase would be involved in the routine turnover of Rb, which would have to be halted in times of stress when a high level of Rb activity is needed.
Tip60-associated proteins and their links to cancer
Because Tip60 and other MYST HATs function in multisubunit protein complexes, additional consideration must be given to studies implicating other complex components in oncogenesis (Figure 2 ). Although these may not directly demonstrate an involvement of the MYST HATs in disease, as the catalytic subunits of their respective complexes they may well contribute to such activities.
One such example is the NuA4 subunit ING3, a member of the ING family of tumour suppressors. ING3 is a co-activator of p53-dependent transcription, and thereby is involved in regulating cell-cycle progression and apoptosis . Interestingly, a recent study observed that it can also facilitate UV-induced apoptosis through the Fas/caspase-8 (Dugan et al., 2002) ; role of p400 in p53-regulated senescence (Chan et al., 2005) ; recruitment of Tip60 by E2F1 (Taubert et al., 2004) ; interaction of EPC1 with the RET-finger protein (RFP) oncogene (Shimono et al., 2000) ; requirement of p400 for adenovirus E1A-mediated cellular transformation (Fuchs et al., 2001) ; interaction between Brd8 (p120) and thyroid hormone receptor (TR) (Monden et al., 1997). pathway, independently of p53 , suggesting a novel mechanism of tumour suppression. Importantly, allelic loss of ING3 has been observed in human head and neck cancers (Gunduz et al., 2002) . (The ING tumour suppressors are discussed in more detail in a separate section below.)
Other NuA4 subunits have also been implicated in malignancy. Majority of such evidence comes from isolated studies, and little or no mechanistic data are available. However, a brief summary is warranted. Amplified copy numbers of the GAS41 (glioma-amplified sequence) gene have been observed in glioblastoma multiforme and astrocytoma (Fischer et al., 1997) . More recently, GAS41 has been implicated in suppression of the p53 tumour suppressor pathway during normal cell growth (Park and Roeder, 2006) . Like Tip60 itself, the NuA4 subunits BAF53a, TRRAP and p400 have been implicated in c-Myc oncogene-mediated cellular transformation (Fuchs et al., 2001; Nikiforov et al., 2002; Park et al., 2002) . Both TRRAP and p400 are also targeted by the adenoviral E1A oncoprotein and are essential for E1A-mediated cellular transformation (Fuchs et al., 2001; Lang and Hearing, 2003) . Although the adenovirus is not associated with human malignancy, this evidence implies that TRRAP and p400 play key roles in cellular regulation and can be subverted to promote oncogenesis. Additionally, MRG15 belongs to a family of proteins that have been linked to cellular senescence (Bertram et al., 1999; Bertram and PereiraSmith, 2001 ). Its deregulation, therefore, can have an effect on cell survival and apoptosis escape.
An intriguing potential link between the NuA4 subunit EPC1 and malignancy came from a recent observation that its coding region can be fused to that of PHF1 (plant homeodomain finger protein 1) through a chromosomal rearrangement found in a subset of uterine sarcomas (Figure 3a ) (Micci et al., 2006) . The resulting chimaeric protein has an open reading frame consisting of the first 581 residues from EPC1 and the entire coding region of PHF1. Within NuA4, the N terminus of EPC1 binds Tip60 and ING3, forming the trimeric piccolo NuA4 (picNuA4), whereas the C terminus bridges it to the rest of the NuA4 complex. Thus, picNuA4 contains HAT activity and, in fact, is the minimal module within NuA4 capable of acetylating chromatin substrates (Boudreault et al., 2003; Doyon et al., 2004; Selleck et al., 2005) . Conversely, PHF1 is homologous to the Drosophila polycomblike protein (PCL), which is associated with transcriptional repression and heterochromatin formation. Both PCL and PHF1 interact with enhancer of zeste, an H3 lysine 27 histone methyltransferase, both in fruit fly and human cells (O'Connell et al., 2001) . Thus, the detection of the EPC1/PHF1 fusion raises a very intriguing possibility that the chimaeric protein diverts the HAT activity of picNuA4 to PHF1's normal targets -genomic regions that are normally maintained in the repressed state (Figure 3a) . Mistargeted acetylation of histone H4 by picNuA4 would lead to unravelling of the heterochromatin, resulting in aberrant gene expression that could easily account for appearance of malignancy.
HBO1 (MYST2)
HBO1 as the catalytic subunit of two related complexes HBO1 was discovered in the context of DNA replication. A critical and therefore exquisitely regulated process, DNA replication begins with the binding of the origin recognition complex (ORC) to the origin of replication. Once there, ORC initiates recruitment of components of the pre-replication complex (pre-RC): Cdc6/Cdc18, Cdt1 and the minichromosome maintenance complex (MCM). Activation of the pre-RC at the onset of the S phase of the cell cycle results in bidirectional DNA replication from the origin (DePamphilis, 2003) . HBO1 (HAT bound to ORC1) was identified through its interactions with ORC1 -the largest subunit of the ORC (Iizuka and Stillman, 1999) , and was also subsequently shown to bind the Mcm-2 component of the MCM complex (Burke et al., 2001) . The early speculation that this MYST HAT plays an active role in DNA replication was recently confirmed with the discovery that HBO1 positively regulates pre-RC assembly and initiation of DNA replication (Aggarwal and Calvi, 2004; Doyon et al., 2006; Iizuka et al., 2006) . This could involve acetylation by HBO1 of pre-RC subunits, as well as of histone substrates which presumably leads to a more accessible chromatin conformation (Iizuka et al., 2006) . Other data also argue for a role of HBO1 throughout S phase, presumably facilitating DNA synthesis during the elongation process (Doyon et al., 2006) .
HBO1 is known to exist in two very similar multiprotein complexes (Figure 1b) (Doyon et al., 2006) . In addition to the HAT, both contain protein products of the gene for apoptosis and differentiation in epithelia (Jade)-1, -2 or -3, hEaf6 (also a subunit of NuA4), and a member of the ING tumour suppressor family -either ING4 or ING5. Peptides corresponding to the MCM proteins were copurified with the ING5-HBO1 but not ING4-HBO1 complex, suggesting that only the former is involved in DNA replication. Unexpectedly, knockdown experiments indicated that HBO1 may be responsible for the bulk of histone H4 acetylation in the cell.
Several reports also link HBO1 to transcription regulation, although the currently available evidence is sparse and conflicting. HBO1 has been variously reported to function as a repressor of transcription by the AR (Sharma et al., 2000) and NF-kB (Contzler et al., 2006) , or as a co-activator for a number of other nuclear hormone receptors (Georgiakaki et al., 2006) . Similarly, contradictory roles in transcription have also been attributed to the Drosophila orthologue of HBO1 (Grienenberger et al., 2002; Miotto et al., 2006) .
HBO1 and cancer
As HBO1 appears to play an essential role in DNA replication, it is reasonable to speculate that defects in its function should have profound negative consequences to the cell and can easily lead to oncogenesis. Notably, the HBO1 coding region has been identified as a common retroviral integration site -an occurrence that can lead to myeloid leukaemia and B/T-cell lymphoma in mice (Suzuki et al., 2002) . Although no mechanistic evidence currently links HBO1's role in replication of the cellular genome to disease, it should be also noted that the cell's DNA replication machinery is frequently utilized by viruses that do not encode a full complement of DNA replication proteins. Both the Epstein-Barr virus and the Kaposi's sarcoma-associated herpesvirus (KSHV) are known to subvert the ORC and MCM complexes for their needs Dhar et al., 2001; Stedman et al., 2004) , and HBO1 has been co-purified with KSHV's origins of replication (Stedman et al., 2004) . Because infections with some viruses are thought to lead to oncogenesis, HBO1's role in DNA replication may thus indirectly contribute to cancer induction.
Other putative links between HBO1 and disease involve its binding partners. Like Tip60, HBO1's interaction with the AR (Sharma et al., 2000) putatively connects it to development of prostate cancer, whereas its functional link with NF-kB (Contzler et al., 2006) may lead to tumour suppression. The interaction between the HBO1 complex subunit Jade-1 and the von Hippel-Lindau tumour suppressor correlates with protection from renal cancer (Zhou et al., 2005) , suggesting that HBO1 function may be connected to that malignancy and to the von Hippel-Lindau disease. The presence of HBO1 in complexes with the tumour suppressors ING4 and -5 (Doyon et al., 2006) further implies that it may play a role in protection from malignancy. ING4 has been shown to suppress loss of contact inhibition in cultured cells and is inactivated in (Micci et al., 2006) , and model of the potential consequences on chromatin function. Domains are labelled as in Figure 1a ; EPc A: EPc A domain; Tudor: Tudor domain. Double-headed arrow represents the position of the protein-protein fusion, (b) Chimaeric proteins involving MOZ and MORF formed as a result of chromosomal translocations in AML (Borrow et al., 1996; Carapeti et al., 1998; Kitabayashi et al., 2001b; Kojima et al., 2003) . Labels are as in Figures 1a and 3a ; KIX: KIX domain; Br: bromodomain; HAT: histone acetyltransferase domain; AD: activation domain; CBP: CBP-binding domain.
various human cancer cell lines (Kim et al., 2004) . It is also a potent inhibitor of glioma and angiogenesis in mouse models (Garkavtsev et al., 2004; Kim et al., 2004) . Both ING4 and ING5 have been reported to enhance transcriptional activity of p53 , and HBO1's histone acetylation activity may facilitate this (Doyon et al., 2006) .
MOZ and MORF

MOZ, MORF and their associated complexes
The MYST acetyltransferase MOZ (monocytic leukaemia zinc-finger protein, also known as MYST3) was first identified as a fusion partner of the CREB-binding protein (CBP) during examination of a specific chromosomal translocation common in acute myeloid leukaemia (AML) (Borrow et al., 1996) . Subsequently, MORF (MOZ-related factor, also known as MYST4) was discovered based on its structural and functional homology to MOZ (Champagne et al., 1999 (Champagne et al., , 2001 Thomas et al., 2000) . Both proteins possess transcriptional activation ability that appears to be separable from their HAT activity, and function as co-activators for two Runt-domain transcription factors -Runx1 and -2 (sometimes referred to as AML1 and -3) (Kitabayashi et al., 2001a; Pelletier et al., 2002; Collins et al., 2006) . Additionally, MORF has been discovered in an unrelated co-activator complex in rat liver (Surapureddi et al., 2002) , whereas transcriptional co-activation by MOZ has been recently linked to expression of a tumour marker gene in liver carcinogenesis (Ohta et al., 2006) . In line with the evidence linking MOZ to leukaemia, two recent studies highlighted its essential role in development and maintenance of hematopoietic stem cells -a function that is apparently also linked to its transcription activation ability (Katsumoto et al., 2006; Thomas et al., 2006) . Similarly, the mouse orthologue of MORF -Querkopf -has been implicated in neural development and maintenance of neural stem cells Merson et al., 2006) , although currently there is no evidence linking it to tumorigenesis in the brain.
MOZ and MORF form similar stable complexes with the ING5 tumour suppressor and the bromodomainand PHD finger-containing (BRPF) proteins 1, 2 or 3 (Figure 1b) . These complexes possess acetyltransferase activity specific for histone H3, and can function as co-activators for Runx-2. As knockdown of ING5 produces a more severe S-phase defect than does deletion of HBO1, it is hypothesized that the MOZ/ MORF-ING5-BRPF complexes also participate in DNA replication (Doyon et al., 2006) . The presence of several domains typically associated with chromatin binding within the BRPF proteins suggests that they are responsible for recruiting the MOZ/MORF complexes to their sites of action. Interestingly, the Caenorhabditis elegans homologue of BRPF has been observed to influence gene expression and development (Chamberlin and Thomas, 2000; Chang et al., 2003) , whereas a recent study has implicated BRPF2 (BRD1) in human neurodevelopment and neurological disorders (Severinsen et al., 2006) .
MOZ/MORF and oncogenesis
In addition to the MOZ-CBP chimaera discovered initially (Borrow et al., 1996; Panagopoulos et al., 2002; Rozman et al., 2004) , chromosomal translocations in AML can also fuse MOZ to the CBP homologue p300 (Kitabayashi et al., 2001b) and to the TIF2 nuclear receptor co-activator (Carapeti et al., 1998) , and MORF to CBP (Figure 3b) (Panagopoulos et al., 2001; Kojima et al., 2003) . With creation of such chimaeric protein products, functional catalytic subunits of one fusion partner become mistargeted by binding domains within the other, resulting in loss of activity at intended genomic locations, aberrant acetylation at other sites, and sequestration of key nuclear regulators. Two groups have observed the MOZ-CBP chimaera to either downregulate or enhance AML1-mediated transcription (Kitabayashi et al., 2001a; Collins et al., 2006) , whereas both MOZ-CBP and MOZ-TIF2 inhibit the activity of the retinoic acid receptor-b2 promoter (Collins et al., 2006) . A number of other genes whose expression is specifically affected by the MOZ-CBP fusion were identified in a recent large-scale study (Camos et al., 2006) . Furthermore, MOZ-TIF2 is able to immortalize committed myeloid progenitor cells and cause AML when introduced into irradiated mice (Huntly et al., 2004) . Thus, chromosomal translocations involving MOZ appear to create bona fide oncogenes.
Additionally, disruption of the MORF coding region due to chromosomal rearrangement distinct from that in AML has been observed in benign uterine smooth muscle tumours (Moore et al., 2004) . In a parallel to HBO1, the MOZ gene has also been identified as a common retroviral integration site leading to myeloid/ lymphoid tumours (Lund et al., 2002) . Together, this evidence suggests that mere loss of MOZ/MORF can contribute to oncogenesis. It is possible that deletion of these MYST HATs disrupts their complex with ING5 which compromises the latter's ability to modulate p53 function .
The ING family of tumour suppressors
As outlined in the above paragraphs, the ING proteins are found in the multisubunit complexes formed by all MYST HATs with the exception of MOF (Figure 1b) . As they are involved in a number of key cellular processes, act as tumour suppressors, and are frequently inactivated in human cancers, a more thorough discussion of their functions is warranted here.
Discovery of ING proteins
The founding member of this protein family, p33ING1, was identified in a screen for genes whose expression was suppressed in malignant cells (Garkavtsev et al., 1996) . Subsequently, p33ING2 (ING1L), p47ING3, p29ING4 and p28ING5 were found through homology searches (Shimada et al., 1998; Nagashima et al., 2001 Nagashima et al., , 2003 Gunduz et al., 2002; Shiseki et al., 2003) . Additionally, human ING1 and -4 transcripts can give rise to variant protein products due to alternative splicing, and some of these are regulated differently and possess functions distinct from their full-length counterparts (He et al., 2005; Unoki et al., 2006; Raho et al., 2007) . All fulllength ING proteins possess a highly conserved C-terminal PHD zinc-finger characteristic of chromatin remodelling factors and a canonical nuclear localization sequence. A recent sequence alignment has revealed two additional regions of high homology at the N terminus and in the middle of the protein (Doyon et al., 2006) .
ING proteins in chromatin-modifying complexes
Major forms of all ING family members have been purified as subunits of distinct evolutionarily conserved multiprotein complexes involved in chromatin modification (Figure 4) . ING3, -4 and -5 are found in complexes with MYST HATs as described above (Doyon et al., 2004 (Doyon et al., , 2006 , whereas ING1 and -2 stably associate with two very similar mSin3 histone deacetylase (HDAC) complexes (Skowyra et al., 2001; Kuzmichev et al., 2002; Doyon et al., 2006) . Notably, the mSin3 complex also contains subunits RBP1 (Rb-binding protein 1) (Lai et al., 2001 ) and BRMS1 (breast cancer metastasis suppressor) (Meehan et al., 2004) . RBP1 facilitates recruitment of this complex by the pocket proteins of the Rb family, which utilize the associated HDAC activity to suppress transcription from E2F-responsive promoters and to shut down DNA replication origins, leading to cell-cycle arrest (Lai et al., 2001) . As its name implies, BRMS1 is capable of suppressing metastasis of several human and mouse cancer cell types (Meehan and Welch, 2003) , and its loss has been correlated with poor prognosis for cancer patients (Hicks et al., 2006; Zhang et al., 2006) . A possible mechanistic explanation for the antimetastatic properties of this protein come from the observations that it is capable of repressing NF-kBmediated transcription (Liu et al., 2006; Samant et al., 2007) , probably due to its association with the Sin3 HDAC complex.
Cellular functions of the ING proteins and their links to cancer
As an in-depth discussion of the entire array of ING functions is beyond the scope of this manuscript, the reader is referred to two excellent recent reviews MYST acetyltransferases and cancer N Avvakumov and J Côté (Campos et al., 2004; Russell et al., 2006) . It is important to point out, however, that the ING family members have been linked to such critical cellular processes as regulation of the cell cycle and proliferation, hormone signalling, DNA transcription and repair, as well as senescence and apoptosis. The key roles of ING proteins in these mechanisms have allowed them to function as potent tumour suppressors. Indeed, loss of their function due to altered levels of expression, mutation or mislocalization has been observed in a number of cancers (Russell et al., 2006) . As the ING proteins possess no known enzymatic activity of their own, they function as adapters bridging the gap between histone-modifying activities of their associated complexes and the genomic sites, where these are needed. DNA-binding proteins that are known to recruit ING family members and their associated complexes include p53 (Garkavtsev et al., 1998; Shiseki et al., 2003; Pedeux et al., 2005) , proliferating cell nuclear antigen (PCNA) (Scott et al., 2001 ) and NF-kB (Garkavtsev et al., 2004) . Thus, the ING proteins serve as a powerful link between chromatin modification and cellular regulation. Additionally, INGs may be able to recruit their associated histone-modifying activities directly to chromatin. Both ING3 and its S. cerevisiae orthologue Yng2 are necessary to enable human or yeast piccolo NuA4 to acetylate chromatin substrates in vitro (Boudreault et al., 2003; Doyon et al., 2004) , suggesting that in each case the ING protein is responsible for the initial binding to chromatin. More recently, the ING PHD finger was shown to specifically bind histone H3 trimethylated on lysine 4 (H3K4me3) -a mark deposited by the mixed lineage leukaemia (MLL) methyltransferase and associated with high transcription levels. The finding that the highly conserved PHD finger of ING2 binds H3K4me3 and recruits an ING-associated repressor complex suggests that this mechanism is capable of rapid shutoff of actively transcribed genes (Shi et al., 2006) . Such a role would be invaluable to the cell in times of genotoxic stress as it would allow for a prompt silencing of proliferation genes, arresting the cell cycle until the DNA damage can be repaired. Activity of the MLL methyltransferase frequently becomes deregulated in several types of leukaemia, leading to aberrant methylation of H3K4 (Linggi et al., 2005) . By recognizing this modification and recruiting their associated histone modification complexes, INGs may suppress inappropriate transcription and stem the onset of malignancy.
Intriguingly, the large-scale study by Camos et al. (2006) noted a remarkable similarity between the panel of genes deregulated by the MOZ-CBP fusion and that observed in leukaemias with rearrangements in the MLL coding region. One possible explanation is that the MOZ-CBP chimaera disrupts the MOZ-ING5 complex, making it unavailable to counteract MLL-mediated methylation in times of stress, and excessive or aberrant methylation by deregulated MLL.
Concluding remarks
The HATs of the MYST family are known to be involved in a wide variety of vital cellular processes such as gene transcription, detection and repair of DNA damage and DNA replication. Ongoing research continuously reveals new ways in which these acetyltransferases impact cellular growth, differentiation, replication and death. Thus, it is not surprising that inappropriate activities of the MYST HATs already have been linked to a number of human maladies including cancer. Additionally, studies of the associated proteins such as MYST HAT complex subunits and other binding partners are constantly providing new and sometimes unexpected links to disease. As the catalytic subunits of their respective complexes, the MYST acetylases are undoubtedly involved in a substantial fraction of such connections.
Ongoing and future research certainly will bring new revelations about the many roles of the MYST family. Molecular investigation of protein-protein interactions and characterization of functional domains, as well as further knockout studies in mice, will help paint the full picture of the cellular functions of these HATs and of the consequences of their activities to organism development and survival. A comprehensive understanding of their normal and aberrant functions is crucial to future design of successful therapies that will be able to target specifically the undesirable activities of these acetyltransferases.
